A major variable in blood coagulation tests is the nature and the amount of surface with which the blood comes in contact. When tests on recalcified plasma are used the methods of preparation and storage of the plasma have also to be considered. The prolonged contact of plasma with a large surface, e.g., with glass powder or asbestos, is accompanied by the loss of many coagulation factors, including prothrombin and fibrinogen (Tocantins, 1945) . Even a more limited exposure to glass, such as is likely to be encountered in normal practice, may be followed by considerable prolongation of the plasma clotting time (Margolis, 1957) . The loss of clotting ability under these conditions is primarily due to the disappearance of the plasma thromboplastin antecedent (Rosenthal, 1955) which is the component most easily destroyed by contact with glass (Margolis, 1958) .
An additional difficulty when dealing with plasma is that, as the number of platelets decreases with increasing centrifugation, the clotting time becomes more and more sensitive to variations in the platelet count and the results become more unpredictable.
Previous investigations (Margolis, 1957) indicated that the clotting time of re-calcified plasma can yield both sensitive and reproducible results when both the contact surface and the platelet content are controlled.
The purpose of the present paper is to demonstrate the usefulness of this procedure for the diagnosis of plasma clotting defects. Methods The patient's plasma is re-calcified after the addition of different preparations derived from normal blood. Instead of relying on the walls of glass tubes as the activating surface, this is supplied much more effectively by the addition of a suspension of kaolin.
By lowering the platelet content the system is made more sensitive, and the differences between normal *Present address: Pharmacology Department, Middlesex Hospital Medical School, London, W 1. and abnormal are magnified. The amount of platelet material is controlled by adding to rapidly-spun plasma a small standard amount of lysed platelets sufficient -to mask the uncontrollable platelet activity left behind after centrifugation of the plasma samples.
All samples of blood and its derivatives are collected and handled in siliconed glassware unless otherwise stated.
Reagents.-The following are required:
(1) Citrated Plasma.-Venous blood is mixed with 20% trisodium citrate (0.2 ml. to 10 ml. of blood) and centrifuged at about 1,000 r.p.m. for 10 min. to obtain platelet-rich plasma. Platelet-poor plasma is obtained by further centrifuging at least at 3,000 r.p.m. for 30 min. and carefully removing the upper two-thirds of the plasma. The platelet count should not exceed 15,000/c.mm. It is important to prevent the formation of dried blood films on the walls of the centrifuge tubes, as this leads to the release of disrupted cellular material which is not easily sedimentable. A convenient method is carefully to transfer the citrated blood into a clean centrifuge tube, minimizing contact of blood with the tube above the level of the meniscus.
(2) Aged Serum.-Normal blood is allowed to clot in a glass centrifuge tube, incubated for several hours at 37' C., and then left for at least 18 hours at room temperature. The serum is decanted and centrifuged at 3,000 r.p.m. or more rapidly; it is then transferred into siliconed tubes and may be stored at -20' C.
(3) Al(OH)s-Adsorbed Plasma ("Alumina Plasma"). -This reagent is prepared according to the methods of Biggs and Macfarlane (1957) . (4 (7) Alternative to Platelet Extract.-As an alternative to the platelet extract, chloroform brain extract (Bell and Alton, 1954) Since kaolin provides an internal activating surface, the clotting time is quite independent of the size of the containers and the absolute volumes of the reagents. These can be proportionally increased, if desired, to facilitate a more accurate measurement of the components. Results
Reproducibility.- Table I Neither is corrected by heated plasma (560 C.), which fact distinguishes these conditions from the plasma thromboplastin antecedent (P.T.A.) de- Stewart, and Davidson, 1958; Margolis, 1958.) The range of the added preparations can be modified to suit individual cases and extended by the inclusion of plasma from cases with known coagulation defects (direct matching).
Discusion
The theoretical considerations, with particular reference to the effect of contact, on which the methods are based, have been discussed elsewhere (Margolis, 1957) . It has since been demonstrated that both the Hageman factor and P.T.A. are concerned in the activation of clotting by contact (Biggs et al., 1958 (Soulier and Larrieu, 1953; Langdell, Wagner, and Brinkhous, 1953) , but suffers from the disadvantage of requiring a stock of suitable abnormal plasma as one of the reagents. Moreover, the results of these methods showed considerable variations between different experiments, presumably owing to the inadequate control of the contact surface.
The present method appears to be free from these drawbacks, the reagents being readily available and the results reproducible from day to day. The sensitivity of the system can be adjusted at will and is apparently limited only by how effectively platelets are removed from the plasma. In addition, the technique is simple and, being based on clearly defined principles, can be easily modified to suit individual requirements.
Summary
A simple, one-stage method for the detection and diagnosis of plasma coagulation defects is described. The test is based on the clotting time of re-calcified plasma in which the conditions are controlled by the addition of kaolin and a diluted platelet or platelet-substitute reagent. The type of deficiency is determined by assessing the corrective effect on the clotting time of the abnormal plasma of various derivatives of normal plasma. The procedure appears to be adequate for detecting even mild degrees of deficiency of plasma clotting factors.
